1. The NOP Receptor System in Neurological and Psychiatric Disorders: Discrepancies, Peculiarities and Clinical Progress in Developing Targeted Therapies

   • Lawrence Toll
   • Andrea Cippitelli
   • Akihiko Ozawa

   Leading Article 31 May 2021 Pages: 591 - 607

   

2. Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug–Drug Interactions and Tolerability

   • Roberta Roberti
   • Carmen De Caro
   • Emilio Russo

   Review Article 16 May 2021 Pages: 609 - 618

3. Irritability in Mood Disorders: Neurobiological Underpinnings and Implications for Pharmacological Intervention

   • Erica Bell
   • Phil Boyce
   • Gin S. Malhi

   Review Article 21 May 2021 Pages: 619 - 641

   

4. Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status

   • Robert L. Findling
   • Shawn A. Candler
   • Jeffrey H. Newcorn

   Review Article Open access 18 May 2021 Pages: 643 - 653

   

5. Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic Study

   • Federico Bertolini
   • Giovanni Ostuzzi
   • The STAR Network Investigators

   Original Research Article Open access 29 March 2021 Pages: 655 - 665

   

6. Effect of a Multi-Layer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adults with ADHD: A Randomized, Double-Blind, Forced-Dose, Placebo-Controlled Trial Followed by a 6-month Open-Label Extension

   • Margaret Danielle Weiss
   • Craig Surman
   • Graeme Donnelly

   Original Research Article Open access 31 May 2021 Pages: 667 - 679

   

7. Erythropoietin Improves Poor Outcomes in Preterm Infants with Intraventricular Hemorrhage

   • Juan Song
   • Yong Wang
   • Changlian Zhu

   Original Research Article Open access 06 May 2021 Pages: 681 - 690

   

8. Diroximel Fumarate in Relapsing Forms of Multiple Sclerosis: A Profile of Its Use

   • Julia Paik

   Adis Drug Q&A 31 May 2021 Pages: 691 - 700

   

9. Correction to: OnabotulinumtoxinA in Chronic Migraine: A Profile of Its Use

   • James E. Frampton

   Correction 21 May 2021 Pages: 701 - 701